Stay updated on Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.

Latest updates to the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page
- CheckyesterdayChange DetectedAdded update dates 2026-03-04 and 2026-03-05 and removed 2026-02-24 and 2026-02-25 from the page's update history.SummaryDifference0.1%

- Check9 days agoChange DetectedThe study record timeline was updated to include new dates (2026-02-24 and 2026-02-25) and remove earlier dates (2026-02-17 and 2026-02-18).SummaryDifference0.1%

- Check16 days agoChange DetectedThe page's update history now shows new dates (2026-02-17 and 2026-02-18) and removes older dates (2026-02-10 and 2026-02-11); the changes affect only the update timeline and not the core study details.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision: v3.4.2 was added on 2026-02-10 and 2026-02-11, while Revision: v3.4.1 entries were removed on 2026-02-03 and 2026-02-04.SummaryDifference0.1%

- Check30 days agoChange DetectedUpdates are limited to routine metadata changes, including a new revision flag (Revision: v3.4.1) and recent update dates (2026-02-04, 2027-03-19, 2026-02-03, 2026-01). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check37 days agoChange DetectedShow glossary was added; minor copy changes include the phrasing of 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new footer note 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.